Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
24.7M
-
Number of holders
-
285
-
Total 13F shares, excl. options
-
19.5M
-
Shares change
-
+36.1K
-
Total reported value, excl. options
-
$3.59B
-
Value change
-
+$747K
-
Put/Call ratio
-
0.12
-
Number of buys
-
142
-
Number of sells
-
-127
-
Price
-
$184.31
Significant Holders of ICU MEDICAL INC/DE - Common Stock (ICUI) as of Q2 2020
326 filings reported holding ICUI - ICU MEDICAL INC/DE - Common Stock as of Q2 2020.
ICU MEDICAL INC/DE - Common Stock (ICUI) has 285 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.5M shares
of 24.7M outstanding shares and own 78.96% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (2.67M shares), JANUS HENDERSON GROUP PLC (2.64M shares), VANGUARD GROUP INC (1.84M shares), BlackRock Inc. (1.7M shares), NUANCE INVESTMENTS, LLC (702K shares), JPMORGAN CHASE & CO (648K shares), STATE STREET CORP (518K shares), Findlay Park Partners LLP (450K shares), Nitorum Capital, L.P. (411K shares), and VICTORY CAPITAL MANAGEMENT INC (403K shares).
This table shows the top 285 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.